TAAT Global Alternatives Inc C.TAAT

Alternate Symbol(s): TOBAF

Healthcare Household & Personal Products

TAAT Global Alternatives Inc. is a vertically integrated consumer product and distribution company. The Company develops, manufactures, and distributes alternative product categories, such as tobacco and reduced-risk alternatives, hemp, kratom, and other emerging consumer packaged goods (CPG) segments. The Company operates through two segments: the sale of non-tobacco and tobacco products. The Company is developing nicotine-free and tobacco-free alternatives to traditional cigarettes. The Company utilizes a proprietary, patent-pending process (including a patent-pending refinement technique) with a blend of all-natural ingredients to provide smokers aged above 21 with an alternative to traditional cigarettes that do not contain nicotine or tobacco. The Company has facilities to include a processing plant in Nevada as well as a distribution center in Canton, Ohio, leveraging existing retail shelf space and pipelines into national wholesale channels.

CSE:TAAT - Post by User

TAAT Global Alternatives Inc > Cse25

<< Previous

Bullboard Posts

Next >>

Comment by amillionorbuston Dec 23, 2020 5:32pm

115 Views

Post# 32174733

RE:Cse25

Going to have to disagree with you BigStacks. Mr Market couldn't give a sh!t about cse25 just like mr market didn't give a sh!t about our website everyone was whining about. Sales and sales channels is what counts. Revenue or the prospect of revenue (eCommerce). Have you bought a stock because it was listed on cse25? Doubt it. It's never even been a fleeting thought in my mind to consider a company based on this factor. Fluff news, plain and simple.

Bigstacks wrote:

Being listed on the cse25 is great news for upcoming news and milestones.

I'm my opinion this will provid a more stable share price moving forward, and put a lot more eyes on taat.

now when we get big news release we'll Likely see much larger moves in share price.

January/February should be great.

Merry Christmas.